Related Experiment Video
Updated: Jun 6, 2026

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy
Published on: May 3, 2013
Tephrosin-induced autophagic cell death in A549 non-small cell lung cancer cells
Jing Li1, Xiao-Lu Wang, Yu-Chun Fang
1Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Abstract:
Anticancer effect of tephrosin (1) has been documented; however, the molecular mechanisms underlying the cytotoxicity of tephrosin in cancer cells remain unclear. In the present paper, the proliferation inhibition rate of several cancer cells was tested using the MTT assay; cell cycle, reactive oxygen species (ROS), and mitochondrial membrane potential (MMP) were determined by flow cytometry; poly(ADP-ribose) polymerase (PARP) cleavage and heat shock protein 90 (Hsp90) expression were evaluated by Western blotting; autophagy was examined by confocal microscopy and light chain 3 (LC3) conversion assay. The results showed that exposure of the cells to tephrosin induced significant proliferation inhibition in a dose-dependent manner, especially on A549 with G(2)/M being arrested. Tephrosin was not found to induce cell apoptosis as PARP cleavage was not detected after 24 h treatment, but the formation of acidic vesicular organelle of autophagy character was found, and autophagy was further confirmed by the increase in the ratio of LC3-II to LC3-I. It was observed that tephrosin induced ROS generation and Hsp90 expression inhibition. These results indicate that tephrosin induces A549 cancer cell death via the autophagy pathway, and the roles of ROS generation and Hsp90 expression inhibition in this process need further study in the future.
Insights
Tephrosin inhibits cancer cell proliferation by inducing autophagy, not apoptosis. This natural compound generates reactive oxygen species (ROS) and inhibits heat shock protein 90 (Hsp90), warranting further investigation into its anticancer mechanisms.
Area of Science:
- Pharmacology
- Molecular Biology
- Cancer Research
Background:
- The anticancer effects of tephrosin are known, but its precise molecular mechanisms in cancer cells are not fully understood.
- Investigating tephrosin's cytotoxicity is crucial for developing novel cancer therapies.
Purpose of the Study:
- To elucidate the molecular mechanisms behind tephrosin-induced cytotoxicity in cancer cells.
- To determine if tephrosin induces apoptosis or autophagy and its effects on cell cycle, ROS, and Hsp90.
Main Methods:
- MTT assay for proliferation inhibition.
- Flow cytometry for cell cycle, reactive oxygen species (ROS), and mitochondrial membrane potential (MMP).
- Western blotting for PARP cleavage and Hsp90 expression; confocal microscopy and LC3 conversion assay for autophagy.
Main Results:
- Tephrosin significantly inhibited cancer cell proliferation in a dose-dependent manner, arresting A549 cells at the G2/M phase.
- Tephrosin did not induce apoptosis (no PARP cleavage) but triggered autophagy, evidenced by acidic vesicular organelle formation and increased LC3-II/LC3-I ratio.
- Tephrosin induced ROS generation and inhibited Hsp90 expression.
Conclusions:
- Tephrosin induces A549 cancer cell death primarily through the autophagy pathway.
- The roles of ROS generation and Hsp90 inhibition in tephrosin's anticancer effects require further research.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Cellular Injury V: Apoptosis and Autophagy
The Extrinsic Apoptotic Pathway
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
